TMS therapy is best known for its FDA-cleared application in treatment-resistant depression, where it has a robust and growing body of clinical evidence behind it. But increasingly, clinicians and patients in Los Angeles and around the country are asking a related question: can TMS therapy effectively treat anxiety?
The answer, informed by emerging research and the clinical experience of practices like NeoPsych in Los Angeles, is a cautiously optimistic yes, with important nuance about which types of anxiety, which patients, and what protocols are most likely to benefit. Under the guidance of Dr. Thomas Hughes, NeoPsych is at the forefront of applying TMS and related neuromodulation technologies to the broader range of conditions that affect patients’ mental health and quality of life.
Understanding Anxiety Disorders
Anxiety disorders are the most common category of mental health conditions, affecting an estimated 40 million adults in the United States. The umbrella term covers several distinct conditions:
- Generalized Anxiety Disorder (GAD): Chronic, excessive worry about a wide range of everyday concerns that is difficult to control
- Social Anxiety Disorder: Intense fear of social situations and scrutiny by others
- Panic Disorder: Recurrent, unexpected panic attacks accompanied by fear of future attacks
- Specific Phobias: Intense, irrational fear of specific objects or situations
- Obsessive-Compulsive Disorder (OCD): Intrusive, unwanted thoughts (obsessions) and repetitive behaviors or mental acts performed to reduce distress (compulsions)
- Post-Traumatic Stress Disorder (PTSD): Anxiety and distress following exposure to traumatic events
Conventional treatments for anxiety disorders, cognitive behavioral therapy (CBT) and/or medication (SSRIs, SNRIs, benzodiazepines) are effective for many patients. But, as with depression, a significant proportion of anxiety sufferers don’t respond adequately to first-line treatments, or cannot tolerate medication side effects. This is the population where TMS therapy is generating the most interest.
The Neuroscience of Anxiety: Why TMS Is a Logical Treatment
To understand why TMS might help anxiety, it’s useful to consider the brain regions and circuits implicated in anxious states.
Anxiety involves dysregulation in a distributed brain network that includes:
- The amygdala: The brain’s threat-detection center, which is hyperactive in anxiety disorders, generating alarm responses to stimuli that don’t warrant them
- The prefrontal cortex: The executive, regulating region of the brain that normally modulates amygdala reactivity; providing the “calm down, it’s okay” signal but shows reduced activity and connectivity in anxiety
- The anterior cingulate cortex: Involved in error detection, conflict monitoring, and emotional regulation
- The insula: Involved in interoceptive awareness and fear processing
In anxiety disorders, the balance between the amygdala (emotional reactivity) and the prefrontal cortex (regulation) is disrupted. TMS can target cortical regions including the prefrontal cortex to modulate this balance.
Importantly, the same dorsolateral prefrontal cortex (DLPFC) that is targeted for depression treatment is also implicated in anxiety regulation. Given that anxiety and depression frequently co-occur (the majority of depressed patients have significant anxiety, and vice versa), TMS for depression often produces collateral benefit for anxiety symptoms as well.
TMS for Specific Anxiety Conditions: What the Research Shows
Generalized Anxiety Disorder (GAD)
Several clinical studies have examined TMS for GAD, with generally positive results. Right-sided inhibitory TMS (using low-frequency stimulation to reduce activity) and left-sided excitatory TMS (using high-frequency stimulation to increase activity) have both been investigated, reflecting the complex laterality of anxiety processing.
A 2019 review of TMS for anxiety disorders concluded that TMS produced meaningful reductions in anxiety symptoms across multiple trials, with the most consistent findings for right-sided low-frequency DLPFC stimulation. Response rates varied but were encouraging, particularly in patients who had not responded to medication.
OCD
TMS is FDA-cleared for OCD treatment specifically, deep TMS targeting the medial prefrontal cortex and anterior cingulate cortex using the BrainsWay H7 coil. This approval in 2018 expanded the landscape of TMS significantly, providing a non-pharmacological option for OCD patients who haven’t responded to SSRIs and ERP (exposure and response prevention therapy).
Clinical trials supporting this approval showed approximately 38% of patients achieved significant response to TMS treatment, compared with 11% in the sham control group a meaningful difference in a population with notoriously treatment-resistant presentations.
PTSD
Post-traumatic stress disorder is one of the most exciting emerging applications for TMS. Several studies have investigated TMS for PTSD, targeting both the right and left DLPFC. Results have been mixed but generally positive, with some trials showing meaningful reductions in PTSD symptom clusters including re-experiencing, avoidance, hyperarousal, and negative cognition and mood.
PTSD and depression share overlapping neural circuits, and given that PTSD patients frequently carry comorbid depression, TMS’s established benefits for depression likely contribute to improvements in PTSD as well.
Research in this area is ongoing, and Dr. Thomas Hughes at NeoPsych stays current with the evolving evidence to inform treatment recommendations for PTSD patients.
Panic Disorder and Social Anxiety
Evidence for TMS in panic disorder and social anxiety is more limited but emerging. The neurobiological overlap with depression and GAD suggests plausible mechanisms, and case reports and small studies have reported beneficial effects.
At NeoPsych, TMS for anxiety beyond OCD and PTSD is offered in the context of an informed, shared decision-making conversation that helps patients understand the strength of evidence for their specific condition and set realistic expectations.
What Does TMS for Anxiety Look Like at NeoPsych?
The evaluation process for TMS at NeoPsych begins with a comprehensive psychiatric assessment by Dr. Thomas Hughes. For anxiety-primary presentations, this includes:
- Detailed psychiatric history and symptom assessment
- Review of previous treatments and responses
- Consideration of comorbid diagnoses (particularly depression, which is extremely common alongside anxiety)
- Discussion of the evidence for TMS in the specific anxiety presentation
- Review of contraindications and logistical considerations
- Development of realistic expectations
The treatment protocol for anxiety may differ from the standard depression protocol in terms of the target site, stimulation frequency, and parameters. For some anxiety presentations, right-sided low-frequency TMS is used; for OCD, deep TMS with the BrainsWay system and a specific coil design is employed. Dr. Hughes will explain the rationale for the protocol recommended for each patient.
TMS as Part of a Comprehensive Anxiety Treatment Plan
TMS is not a standalone treatment it’s most powerful when integrated into a comprehensive anxiety treatment plan. At NeoPsych, TMS for anxiety is typically paired with:
Cognitive Behavioral Therapy: CBT remains the gold standard psychotherapy for anxiety disorders. TMS and CBT appear to complement each other well, some research suggests that TMS may enhance the neuroplastic changes produced by therapy, potentially improving CBT outcomes.
Medication management: For some patients, TMS and medication together produce better outcomes than either alone. Dr. Hughes provides medication management services and can optimize this combination.
Lifestyle interventions: Sleep quality, exercise, and stress reduction all have meaningful effects on anxiety and interact with the neurobiological targets of TMS.
Who Is Most Likely to Benefit?
Based on current evidence and clinical experience at NeoPsych, anxiety patients most likely to benefit from TMS include those who:
- Have not responded adequately to one or more medication trials
- Have significant OCD that hasn’t responded to SSRIs and ERP (strong evidence base)
- Have comorbid depression and anxiety (TMS for depression frequently improves anxiety as well)
- Cannot tolerate medication side effects
- Have PTSD with or without comorbid depression
Anxiety presentations that tend to respond less predictably include panic disorder with minimal treatment history and specific phobias (where behavioral treatments remain most effective).
The Promise of Personalized Neuromodulation
The future of TMS for anxiety likely involves increasingly personalized targeting using neuroimaging, biomarkers, or functional connectivity data to identify the optimal brain targets for each individual patient. This precision medicine approach is being actively researched and represents an exciting frontier.
At NeoPsych, Dr. Thomas Hughes is committed to bringing the most current evidence and the most individualized approach to every patient who walks through the door. If anxiety is limiting your life and conventional treatments haven’t provided adequate relief, a consultation at NeoPsych in Los Angeles is a meaningful next step.
Contact NeoPsych today to schedule your evaluation and explore whether TMS therapy is the right option for your anxiety.